NGF and Miyoshi myopathy: In this study, we investigate the impact of continuous M-Len therapy after ASCT and MRD monitoring by carrying out NGF-MRD at Day + 100 after ASCT and identifying subgroups of patients with distinct outcomes among a series of 53 real-world patients with MM treated outside clinical trials in Brazil.